Haleos Labs Ltd

Communication To Shareholders (TDS Related)

Enclosed email communication sent to Shareholders.

Company Update / General View filing →

Newspaper Publication (Financial Results)

Enclosed -- newspaper advertisement for Q1F27 results.

Company Update / General View filing →

Independent Directors (Reappointed)

Dr. Mannam Malakondaiah and Dr. Srinivas Samavedam were reappointed for a second term of 5 years w.e.f. November 13, 2026, subject to approval of shareholders.

Company Update / General View filing →

Update (Material Subsidiary)

Mahi Drugs Private Limited appointed Cost Auditors for the year 2026-27 and Mr. Vincent P Asrao as Nominee Director.

Company Update / General View filing →

Newspaper Publication (Postal Ballot)

Enclosed - Newspaper advertisement.

Company Update / General View filing →

Events Calendar (Postal Ballot)

Enclosed: events calendar for the Postal Ballot.

Company Update / General View filing →

Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

Postal Ballot Notice (30.07.2026 to 28.08.2026)

AGM/EGM / Postal Ballot View filing →

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Enclosed -- RTA certificate.

Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

Closure of Trading Window

Intimation of Closure of Trading Window.

Insider Trading / SAST / Closure of Trading Window View filing →

Transfer Of Shares (IEPF Suspense Account)

Communication to shareholders regarding transfer of shares to the IEPF suspense account for the unclaimed dividend for the year 2018-19.

Company Update / General View filing →